Author: Bayh-Dole Coalition

02 Mar What Tech Transfer Experts Are Saying About March-In Rights, 3/2/2022

Posted at 17:52h Backgrounders, Issue Briefs, and White Papers, Resources

Share

Read More

22 Feb Here Is How Biden Can Attack High Drug Prices Without Congress

Posted at 11:33h Other Media

Share

Johnathan Cohn
HuffPost, 2/20/2022
Also published in Yahoo News ...

Read More

17 Feb Stalled US drug price law drives experts to think outside box on lopsided costs

Posted at 11:11h Other Media

Share

Michael Gibney
S&P Global Market Intelligence, 2/16/2022 ...

Read More

15 Feb The new lightning rod in the fight over high drug prices

Posted at 12:20h Other Media

Share

Nicholas Florko
STAT, 2/15/22...

Read More

11 Feb Marching in again? Latest Xtandi petition raises questions on if NIH has changed its tune

Posted at 13:27h Other Media

Share

Zachary Brennan
Endpoints News, 2/10/2022 ...

Read More

01 Feb Scrip Asks…What Does 2022 Hold For Biopharma? Part 1: Markets, Competition And Business Strategy

Posted at 14:22h Other Media

Share

Eleanor Malone
Scrip Pharma Intelligence, 2/1/2022 ...

Read More

31 Jan Will the Biden administration approach march-in rights like Trump? Fight over pricey cancer drug offers a test

Posted at 17:58h Other Media

Share

Ed Silverman
STAT, 1/31/2022 ...

Read More

28 Jan The Legacy of Bayh-Dole’s Success on U.S. Global Competitiveness Today, 1/12/2022

Posted at 11:42h Backgrounders, Issue Briefs, and White Papers, Resources

Share

Read More

19 Jan Knowledge Ecology International’s New March-In Petition is Déjà vu All Over Again – With One Twist

Posted at 10:05h Op-Eds

Share

Joseph P. Allen
IPWatchdog, 1/18/2022 ...

Read More

18 Jan Could a fix on drug prices harm university ag tech-transfers?

Posted at 13:38h Other Media

Share

Mikkel Pates
AgWeek, 01/17/2022 ...

Read More